Dunwoody R&D Tax Credit Benefits for Your Business

R&D Tax Credits for Dunwoody, Georgia Businesses

Dunwoody, Georgia, hosts top R&D companies like State Farm, Cox Enterprises, Mercedes-Benz USA, InterContinental Hotels Group, and WellStar Health System. These organizations focus on insurance technology, telecommunications, automotive innovation, and healthcare research. The R&D tax credit helps them offset research expenses, lowering their tax liability. By reinvesting these savings into innovation, employee training, or operational improvements, these companies can enhance their competitive edge, accelerate product development, and improve business performance.

Find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 400 West Peachtree Street NW, Atlanta, Georgia is less than 20 miles away from Dunwoody and provides R&D tax credit consulting and advisory services to Dunwoody and the surrounding areas such as: Atlanta, Sandy Springs, South Fulton, Roswell and Johns Creek.

If you have any questions or need further assistance, please call or email our local Georgia Partner on (404) 448-1354.
Feel free to book a quick teleconference with one of our Georgia R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Dunwoody, Georgia Patent of the Year – 2024/2025

Endoluxe Inc. has been awarded the 2024/2025 Patent of the Year for its innovative medical device designed to improve endoscopic procedures. Their invention, detailed in U.S. Patent No. 11864730, titled ‘Systems, apparatuses, and methods for endoscopy’, uses a flexible, controllable endoscope system with enhanced maneuverability and precision.

This new endoscope design features a multi-segmented, flexible body controlled by an advanced actuator system. The technology allows medical professionals to navigate complex anatomical pathways more easily and with greater accuracy. This flexibility reduces patient discomfort and improves the success rate of diagnostic and therapeutic procedures.

Endoluxe’s invention also includes a user-friendly interface that gives clinicians precise control over the endoscope’s movement. This improvement enables more detailed imaging and access to hard-to-reach areas inside the body, potentially leading to earlier detection of diseases and better treatment outcomes.

Endoscopic procedures are critical in modern medicine, but challenges in device maneuverability can limit their effectiveness. This innovation addresses those challenges by enhancing device responsiveness without sacrificing patient safety.

The patent highlights a significant step forward in minimally invasive medical technology. By combining flexibility, control, and ease of use, Endoluxe Inc.’s invention promises to improve patient care and expand the capabilities of endoscopic diagnostics and treatments worldwide.